Pharmaceutical News

RSS

Use of RAAS inhibitors reduced aneurysm rupture risk by 18%, finds study

A multi-center study of more than 3,000 people with high blood pressure and brain aneurysms found that the use of RAAS inhibitors, a class of blood pressure lowering medications, reduced the risk of an aneurysm rupture by 18%, according to new research published today in Hypertension, a peer-reviewed journal of the American Heart Association.

3 Jun 2022

Women are seldom informed about contraceptive failure following common anesthetic use

Women undergoing operations are not being routinely informed that a common anesthetics may make their contraception less effective, putting them at risk of an unplanned pregnancy, new research being presented at Euroanaesthesia, the annual meeting of the European Society of Anaesthesiology and Intensive Care (ESAIC) in Milan, Italy (4-6 June), suggests.

3 Jun 2022

Contraceptive pills may affect some women’s moods

Finding the right type of contraception is important. Oral contraception – also known as the pill – is the most popular and widely used method. In the June edition of Australian Prescriber, Dr Eveline Mu and Professor Jayashri Kulkarni from the Monash Alfred Psychiatry Research Centre in Melbourne write how contraceptive pills may affect some women’s moods.

3 Jun 2022

More than 4 out of 10 adults in Australia have difficulty in understanding medicine instructions

More than 4 out of 10 adults in Australia are not able to read and understand important information about their medicines. Jo Medlin, President of the Council for Adult Literacy emphasised the importance of considering health literacy in her keynote presentation at today’s National Medicine Symposium.

31 May 2022

Virtual event hosted by NPS MedicineWise focuses on improving health literacy

The burden of health literacy is commonly placed on consumers, however, it is also the responsibility of the healthcare sector – health professionals, service providers and health organisations to reduce the complexity of the healthcare system.

31 May 2022

Highest medicinal dose of cannabidiol is driver-safe, study confirms

Millions of consumers and patients around the world will be heartened by the results of the latest study on cannabis and driving.

30 May 2022

Topical ocular administration of progesterone could be viable treatment for retinitis pigmentosa

Retinitis pigmentosa is a degenerative disease affecting the photoreceptor cells in the retina, known as cones and rods.

30 May 2022

Diabetes drug can improve the efficiency and efficacy of antibacterial treatments

Old dogs may not learn new tricks, but old drugs can, according to a research team based in China. The collaboration found that Metformin, a small molecule drug that has been used to treat type II diabetes for more than 50 years, can improve the efficiency and efficacy of antibacterial treatments for quick wound-healing in mice.

27 May 2022

Novavax missed its global moonshot but is angling to win over mRNA defectors

Novavax hitched its wagon to the global coronavirus pandemic. Before most Americans truly grasped the scope of the danger, the small Maryland biotech startup had secured $1.6 billion in U.S. funding for its covid vaccine. Its moonshot goal: delivering 2 billion shots to the world by mid-2021.

26 May 2022

Mucosal COVID vaccine candidate powerfully protective in macaques

A recent research paper posted to the bioRxiv* preprint server illustrated the protective efficacy of the intranasal pediatric parainfluenza virus-vectored coronavirus disease 2019 (COVID-19) vaccine prospect, B/HPIV3/S-6P, in macaques.

26 May 2022

A study on the safety of BNT162b2 COVID vaccine in children under five

In a recent research paper posted to the medRxiv* preprint server, scientists explored the safety of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) BNT162b2 vaccine in children under five years of age.

25 May 2022

Association between reactogenicity and immunogenicity in SARS-CoV-2 mRNA-1273 vaccination

A recent study currently under review at Scientific Reports journal and posted to the Research Square* preprint server demonstrated a potential positive correlation between reactogenicity and immunogenicity of coronavirus disease 2019 (COVID-19) vaccination.

25 May 2022

Study estimates $1.8 billion in Medicare spending on drugs with accelerated approval

The U.S. federal government spent an estimated $1.8 billion in Medicare funds in 2019 on drugs whose clinical benefits have yet to be confirmed by the Food and Drug Administration, a new study led by researchers from the Johns Hopkins Bloomberg School of Public Health suggests.

24 May 2022

Tribal pharmacy dispenses free meds and fills gaps for Native Americans in the city

Tucked away on a side street near downtown, the Mashkiki Waakaa'igan Pharmacy offers its Native American clientele the services of any ordinary drugstore — it dispenses critical medication and provides consultation on treatments.

24 May 2022

Findings from the CoVaccS study on parental intention to vaccinate children against COVID

In the current preprint posted to the medRxiv* server, the researchers looked at UK parental intention to vaccinate their children during a time of selective pediatric vaccination.

24 May 2022

Efficacy study of Paxlovid and Molnupiravir in real-world settings shows positive results

In a recent study posted to the medRxiv* pre-print server, researchers evaluated the effectiveness of oral severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antivirals, molnupiravir (Lagevrio) or nirmatrelvir/ritonavir (Paxlovid) in a real-world setting.

24 May 2022

BNT162b2 vaccine induces robust SARS-CoV-2 immunity in children

In a recent study posted to the medRxiv* pre-print server, researchers evaluated coronavirus disease 2019 (COVID-19) vaccine-induced humoral immune response in five to 11-year-old children.

23 May 2022

Olverembatinib a potent inhibitor of Omicron NTD-mediated cytokine release

Researchers determine whether mutations in the Omicron NTD influence its potential to stimulate myeloid cells and enhance inflammatory cytokine release.

22 May 2022

Novel brain-permeable Cdk5 inhibitor alters neurobehavior in mice

James Bibb, Ph.D., and colleagues have described a novel preclinical drug that could have the potential to combat depression, brain injury and diseases that impair cognition. The drug, which notably is brain-permeable, acts to inhibit the kinase enzyme Cdk5.

20 May 2022

Medicinal cannabis can be considered as alternative to pain relief medicines for cancer patients

A comprehensive assessment of the benefits of medical cannabis for cancer-related pain found that for most oncology patients, pain measures improved significantly, other cancer-related symptoms also decreased, the consumption of painkillers was reduced, and the side effects were minimal.

20 May 2022

Previous
1
...
77
78
79
80
81
82
83
...
1434
Next

Pharmaceutical News

Use of RAAS inhibitors reduced aneurysm rupture risk by 18%, finds study

Women are seldom informed about contraceptive failure following common anesthetic use

Contraceptive pills may affect some women’s moods

More than 4 out of 10 adults in Australia have difficulty in understanding medicine instructions

Virtual event hosted by NPS MedicineWise focuses on improving health literacy

Highest medicinal dose of cannabidiol is driver-safe, study confirms

Topical ocular administration of progesterone could be viable treatment for retinitis pigmentosa

Diabetes drug can improve the efficiency and efficacy of antibacterial treatments

Novavax missed its global moonshot but is angling to win over mRNA defectors

Mucosal COVID vaccine candidate powerfully protective in macaques

A study on the safety of BNT162b2 COVID vaccine in children under five

Association between reactogenicity and immunogenicity in SARS-CoV-2 mRNA-1273 vaccination

Study estimates $1.8 billion in Medicare spending on drugs with accelerated approval

Tribal pharmacy dispenses free meds and fills gaps for Native Americans in the city

Findings from the CoVaccS study on parental intention to vaccinate children against COVID

Efficacy study of Paxlovid and Molnupiravir in real-world settings shows positive results

BNT162b2 vaccine induces robust SARS-CoV-2 immunity in children

Olverembatinib a potent inhibitor of Omicron NTD-mediated cytokine release

Novel brain-permeable Cdk5 inhibitor alters neurobehavior in mice

Medicinal cannabis can be considered as alternative to pain relief medicines for cancer patients

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News